Genetic Testing Services
Labryo Reproductive Services partners with Orchid Health
Preimplantation Genetic Testing involves analyzing a few cells from an embryo to screen for genetic or chromosomal abnormalities before transfer. The different types include PGT-A (for aneuploidy, or chromosomal errors), PGT-M (for single-gene disorders), and PGT-SR (for structural rearrangements). The key highlight is the ability to select genetically healthy embryos, which significantly lowers the risk of miscarriage and a baby being born with a genetic disorder. The primary benefit is increasing the likelihood of a successful pregnancy and the birth of a healthy child.
The Next Generation of Genetic Screening: Whole Genome Sequencing
At Labryo Reproductive Services, our commitment to excellence is reflected in our partnerships. We are proud to be a premier partner of Orchid Health, a leader in whole-genome embryo screening. This exclusive collaboration allows us to offer our patients the most comprehensive preimplantation genetic testing (PGT) available today: Preimplantation Genetic Testing - Whole Genome Sequencing (PGT-WGS).
Unlike traditional PGT methods that analyze less than 1% of an embryo's genome, Orchid's technology sequences over 99% of an embryo's DNA. This provides an unprecedented level of insight, combining multiple screens into a single, comprehensive report. This is a game-changer for intended parents seeking to make the most informed decisions about their family's health.
The Orchid Health Advantage for Intended Parents Using Donor Gametes
The benefits of PGT-WGS are particularly significant for intended parents using donor eggs or sperm. While donors undergo rigorous screening, traditional carrier panels may not capture all potential genetic risks. Orchid's PGT-WGS offers a critical layer of protection by:
Detecting De Novo Mutations: PGT-WGS can identify new genetic mutations that were not present in the donor's known genetic profile. These de novo mutations can arise spontaneously and are a leading cause of severe pediatric conditions.
Comprehensive Monogenic Disease Screening: The test screens for over 1,200 single-gene disorders simultaneously, including those linked to neurodevelopmental disorders, birth defects, and hereditary cancers. This provides a safety net against conditions that might have been missed by standard donor screening.
Enhanced Chromosomal Analysis: PGT-WGS offers superior detection of chromosomal abnormalities (PGT-A), including smaller deletions and duplications that traditional tests might not catch. This ensures that the embryos selected are chromosomally sound.
By offering Orchid Health's advanced PGT-WGS, we empower you with the most detailed genetic information possible, providing confidence and peace of mind as you build your family. This partnership reflects our dedication to using cutting-edge science to help you achieve a healthy, successful pregnancy.